Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.

@article{Yamada2009DuraMG,
  title={Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes.},
  author={Masahito Yamada and M Noguchi-Shinohara and Tsuyoshi Hamaguchi and Ichiro Nozaki and Tetsuyuki Kitamoto and Takeshi Sato and Yosikazu Nakamura and Hidehiro Mizusawa},
  journal={Neuropathology : official journal of the Japanese Society of Neuropathology},
  year={2009},
  volume={29 5},
  pages={609-18}
}
Up to February 2008, a total of 132 patients with dura mater graft-associated Creutzfeldt-Jakob disease (dCJD) have been identified in Japan, accounting for a majority of the world's patients with dCJD. The patients received dura mater grafts from 1978 to 1993. Lyodura (B. Braun, Melsungen, Germany) was used for all the patients in whom the brand name of the dura mater could be identified. After the incubation period of 1 to 25 years (mean, 11.8 years), CJD appeared from 1985 through to 2006… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

Similar Papers

Loading similar papers…